Coronary Artery Lesions

Cardiovascular
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

OrbusNeich
OrbusNeichChina - Hong Kong
1 program
1
coronary stentingPhase 21 trial
Active Trials
NCT00967902Completed180Est. Sep 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OrbusNeichcoronary stenting

Clinical Trials (1)

Total enrollment: 180 patients across 1 trials

NCT00967902OrbusNeichcoronary stenting

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

Start: Nov 2009Est. completion: Sep 2015180 patients
Phase 2Completed

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space